Adverts

Open Access Articles- Top Results for Duligotumab

Duligotumab

Duligotumab?
Monoclonal antibody
Type Whole antibody
Source Human
Target HER3
Clinical data
Identifiers
1314238-96-4
None
Chemical data

Duligotumab (INN) is a human monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to HER3.[1]

References

  1. ^ World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107" (PDF). WHO Drug Information 26 (2). 


Lua error in package.lua at line 80: module 'Module:Buffer' not found.